SCHEMBL25219418

SCHEMBL25219418

N#Cc1c(Br)nn([C@H]2CCN(C(=O)O)C2)c1N

nearest known ligand 0.40

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 4/20 0.40
JAK3 P52333 4/20 0.40
JAK1 P23458 3/20 0.39
BTK Q06187 8/20 0.35
FGFR1 P11362 7/20 0.35
FGFR4 P22455 7/20 0.35
FGFR3 P22607 4/20 0.34
KDM5A P29375 1/20 0.33
FGFR2 P21802 3/20 0.33
EGFR P00533 1/20 0.32
SRC P12931 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28768608 1.00 JAK2 (0.40) JAK2JAK3JAK1BTKFGFR1
SCHEMBL26617088 0.87 JAK2 (0.36) JAK2JAK3JAK1KDM5A
SCHEMBL26617086 0.87 JAK2 (0.36) JAK2JAK3JAK1KDM5A
SCHEMBL21114946 0.83 GPR119 (0.40) JAK2JAK1BTKEGFRSRC
SCHEMBL21114947 0.83 GPR119 (0.40) JAK2JAK1BTKEGFRSRC
SCHEMBL28703609 0.83 GPR119 (0.40) JAK2JAK1BTKEGFRSRC
SCHEMBL26617082 0.82 FGFR1 (0.34) JAK2JAK3JAK1FGFR1FGFR4
SCHEMBL26617081 0.82 FGFR1 (0.34) JAK2JAK3JAK1FGFR1FGFR4
SCHEMBL21192561 0.80 FGFR1 (0.42) BTKFGFR1FGFR4FGFR3FGFR2
SCHEMBL28766362 0.80 FGFR1 (0.42) BTKFGFR1FGFR4FGFR3FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023107870-A1 INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES KINNATE BIOPHARMA INC. (US) 2023-06-15 WO disclosed
CN-115867547-A 1H-pyrazole-4-amide derivative, and preparation method and application thereof 上海和誉生物医药科技有限公司 2023-03-28 CN disclosed
CN-109843873-B Alkyne heterocyclic compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-06-17 CN disclosed